ClinicalTrials.gg
CompletedNCT03400449Updated Nov 13, 2019Results posted

Video Versus Conversational Contraceptive Counseling During Maternity Hospitalization

An interventional study of Video counseling and Conversational counseling in Contraceptive Usage and Contraception Behavior, sponsored by Oregon Health and Science University. Completed at 2 sites in Colombia. Open to female participants aged 14 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-11-13.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Apr 2015, registered Dec 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
14 Years to 45 Years
Sex
Female
01

Study summary

A randomized trial comparing LARC uptake and satisfaction after either video or conversational-based contraceptive counseling for pregnant women in labor.

Read the detailed description

This was a multi-center randomized, controlled trial examining contraceptive counseling in the setting of long-acting reversible contraception (LARC) uptake and immediate provision. At two urban public hospitals with large adolescent populations, participants were randomized to a structured, in-person conversation with a trained counselor or a 14-minute video providing the same information. Both participant groups were provided written materials and both had the opportunity to ask questions of the counselor. The total time to complete counseling was measured, as well as participant satisfaction, pre- and post-intervention contraceptive knowledge, and intended postpartum contraceptive method.

02

Conditions studied

  • Contraceptive Usage
  • Contraception Behavior
03

In context

Contraception Behavior

132 studies on the registry are indexed under Contraception Behavior; 20 are open to participants now.

This study's enrollment of 240 is below the median of 382 across 106 interventional studies indexed under Contraception Behavior.

Browse Contraception Behavior studies →

Lead sponsor

Oregon Health and Science University is the lead sponsor of 696 studies on the registry; 131 are open to participants now.

Of its 52 completed or terminated interventional studies of FDA-regulated products, 39 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Live pregnancy >20 weeks gestation
  • Admission to maternity ward for labor
  • Age >14

Exclusion criteria

Exclusion Criteria:

  • Pain >=8 on Wong-Baker FACES pain scale
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
240 participants (actual)

Study arms

  • Active comparator
    Video counseling

    The video group watched a 13.75 minute video of a local Colombian counselor reading a script of the same information provided by conversational counseling and had a chance to ask questions at the end.

    Other: Video counseling

  • Active comparator
    Conversational counseling

    The conversation group participated in a structured, face-to-face conversation with a trained counselor.

    Other: Conversational counseling

Interventions

  • OtherVideo counseling

    Video counseling

  • OtherConversational counseling

    Conversational counseling

06

What researchers measure

Primary outcomes

  1. Total Counseling Time

    Duration of counseling in minutes (from initiation of counseling to conclusion of all questions answered.) The clock was not stopped for breaks, which were allowed as needed.

    Time frame: Immediately following the intervention, an average of less than 30 minutes

Secondary outcomes

  1. Knowledge Scores

    Mean total correct answer (score) to 7 multiple-choice contraceptive knowledge questions. Total possible score is 0-7, with 7 representing 100% correct answers. Score measured after completion of the knowledge questionnaire, on average less than one hour, before (pre) and after (post) counseling.

    Time frame: One hour

  2. Number of Participants Initiating Postpartum LARC Uptake

    Number of participants initiating long-acting reversible contraception (LARC - intrauterine device (IUD) or implant) prior to hospital discharge.

    Time frame: Assessed at the time of hospital discharge, on average less than 2 days

07

Results

Posted Jun 19, 2019

Participant flow

Participant flow — Overall Study
MilestoneVideo CounselingConversational Counseling
Started121119
Completed120119
Not completed10

Outcome measures

PrimaryTotal Counseling Time

Duration of counseling in minutes (from initiation of counseling to conclusion of all questions answered.) The clock was not stopped for breaks, which were allowed as needed.

Time frame:
Immediately following the intervention, an average of less than 30 minutes
Reported as:
Mean · minutes
Total Counseling Time
minutesVideo CounselingConversational Counseling
Total Counseling Time16.8 ± 4.616.3 ± 4.6
SecondaryKnowledge Scores

Mean total correct answer (score) to 7 multiple-choice contraceptive knowledge questions. Total possible score is 0-7, with 7 representing 100% correct answers. Score measured after completion of the knowledge questionnaire, on average less than one hour, before (pre) and after (post) counseling.

Time frame:
One hour
Reported as:
Mean · score on a scale
Knowledge Scores
score on a scaleConversational CounselingVideo Counseling
Pre-counseling3.1 ± 1.53.1 ± 1.5
Post-counseling5.3 ± 1.05.1 ± 1.2
SecondaryNumber of Participants Initiating Postpartum LARC Uptake

Number of participants initiating long-acting reversible contraception (LARC - intrauterine device (IUD) or implant) prior to hospital discharge.

Time frame:
Assessed at the time of hospital discharge, on average less than 2 days
Reported as:
Count of participants · Participants
Number of Participants Initiating Postpartum LARC Uptake
ParticipantsConversational CounselingVideo Counseling
Number of Participants Initiating Postpartum LARC Uptake4644

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Video Counseling0/120 (0%)0/120 (0%)0/120 (0%)
Conversational Counseling0/119 (0%)0/119 (0%)0/119 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Video CounselingConversational CounselingTotal
<=18 years202343
Between 18 and 65 years10096196
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Video CounselingConversational CounselingTotal
Female120119239
Male000
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Video CounselingConversational CounselingTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Video CounselingConversational CounselingTotal
Colombia120119239
08

Study locations

2 sites
  • Maternidad Rafael Calvo
    Cartagena, Colombia
  • Metrosalud Manrique
    Medellín, Colombia
09

References and documents

Publications

  • Hersh AR, Munoz LF, Rincon M, Alvarez C, Tolosa JE, Moreno DJ, Rubio M, Vargas JC, Edna F, Taborda N, Baldwin MK. Video compared to conversational contraceptive counseling during labor and maternity hospitalization in Colombia: A randomized trial. Contraception. 2018 Sep;98(3):210-214. doi: 10.1016/j.contraception.2018.05.004. Epub 2018 May 9. PubMed 29752923 ↗

Individual participant data

Plan to share: No — Individual sites hold the paper data under monitoring plan through their site Institutional Review Board (IRB - University de Antioquia). They entered de-identified data electronically into REDCap for our use for analysis. We have shared aggregate analysis with the individual sites.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2015 to primary completion in Aug 2016, 15 months.

Results were first posted in Jun 2019, 2 years 10 months after primary completion.

Of 64 non-industry interventional studies with no phase under Contraception Behavior, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 40. This study's 15 months is below that.

Counting every sponsor, half of 64 studies reached it within 20 months; a quarter within 13 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 20, 2017
First posted
Jan 17, 2018
StartActual
Apr 28, 2015
Primary completionActual
Aug 7, 2016
CompletionActual
Aug 7, 2016
Results first posted
Jun 19, 2019
Last update
Nov 13, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03400449
Collaborators
Universidad de Antioquia
Responsible party
Maureen Baldwin (Assistant Professor, Oregon Health and Science University) — Principal investigator
First posted
Jan 17, 2018
Start date
Apr 28, 2015
Primary completion
Aug 7, 2016
Completion
Aug 7, 2016
Results posted
Jun 19, 2019
Last update
Nov 13, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion